Insmed, Inc. (INSM)
109.96
+5.52
(+5.29%)
USD |
NASDAQ |
Nov 04, 16:00
109.96
0.00 (0.00%)
After-Hours: 16:28
Insmed Total Return Price : 109.96 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 104.44 |
| November 02, 2026 | 109.31 |
| October 30, 2026 | 112.58 |
| October 29, 2026 | 111.59 |
| October 28, 2026 | 96.98 |
| October 27, 2026 | 94.96 |
| October 26, 2026 | 93.33 |
| October 23, 2026 | 93.39 |
| October 22, 2026 | 95.06 |
| October 21, 2026 | 94.04 |
| October 20, 2026 | 95.67 |
| October 19, 2026 | 95.29 |
| October 16, 2026 | 96.27 |
| October 15, 2026 | 99.21 |
| October 14, 2026 | 97.79 |
| October 13, 2026 | 96.79 |
| October 12, 2026 | 98.56 |
| October 09, 2026 | 100.60 |
| October 08, 2026 | 100.48 |
| October 07, 2026 | 101.74 |
| October 06, 2026 | 105.23 |
| October 05, 2026 | 103.83 |
| October 02, 2026 | 111.12 |
| October 01, 2026 | 108.59 |
| September 30, 2026 | 114.14 |
| Date | Value |
|---|---|
| September 29, 2026 | 115.63 |
| September 28, 2026 | 117.67 |
| September 25, 2026 | 117.83 |
| September 24, 2026 | 121.55 |
| September 23, 2026 | 118.34 |
| September 22, 2026 | 120.82 |
| September 21, 2026 | 121.00 |
| September 18, 2026 | 120.00 |
| September 17, 2026 | 123.98 |
| September 16, 2026 | 122.58 |
| September 15, 2026 | 119.92 |
| September 14, 2026 | 125.30 |
| September 11, 2026 | 129.41 |
| September 10, 2026 | 127.28 |
| September 09, 2026 | 128.80 |
| September 08, 2026 | 124.89 |
| September 04, 2026 | 126.29 |
| September 03, 2026 | 126.68 |
| September 02, 2026 | 126.63 |
| September 01, 2026 | 121.51 |
| August 31, 2026 | 121.82 |
| August 28, 2026 | 118.54 |
| August 27, 2026 | 121.39 |
| August 26, 2026 | 124.39 |
| August 25, 2026 | 123.89 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Gilead Sciences, Inc. | 174.45 |
| Vertex Pharmaceuticals, Inc. | 549.06 |
| Alnylam Pharmaceuticals, Inc. | 160.91 |
| Incyte Corp. | 122.91 |
| United Therapeutics Corp. | 607.42 |